Reversal of Adrenergic Desensitization in Prenatally Stressed Rats by P38 Map Kinase Inhibitor, SB203580

被引：0
|
作者：
Chen, Fangping [1 ]
Kan, Hong [1 ]
Xie, Sherry [1 ]
Beto, Robert J. [1 ]
Warden, Bradford E. [1 ]
Jain, Abnash C. [1 ]
Finkel, Mitchell S. [1 ,2 ]
机构：
[1] W Virginia Univ, Morgantown, WV 26506 USA
[2] Louis A Johnson VA Med Ctr, Clarksburg, WV USA
来源：
FASEB JOURNAL | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line
    Şükrü Aydın Düzgün
    Azmi Yerlikaya
    Sezgin Zeren
    Zülfü Bayhan
    Emrah Okur
    İhsan Boyacı
    Cytotechnology, 2017, 69 : 711 - 724
  • [32] SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance
    Barancík, M
    Bohácová, V
    Kvackajová, J
    Hudecová, S
    Krizanová, O
    Breier, A
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (01) : 29 - 36
  • [33] p38 Inhibitor SB203580 sensitizes the resveratrol-induced apoptosis in human lung adenocarcinoma (A549) cells
    Li, Haiyang
    Wang, Xiaoping
    Chen, Tongsheng
    Qu, Junle
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2012, 26 (07) : 251 - 257
  • [34] SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus
    Saleshando, G
    O'Connor, JJ
    NEUROSCIENCE LETTERS, 2000, 288 (02) : 119 - 122
  • [35] The p38 mitogen-activated protein kinase inhibitor, SB203580, activates the serine/threonine kinase Raf-1 in vascular smooth muscle cells.
    Daum, G
    Kalmes, A
    Clowes, AW
    FASEB JOURNAL, 1999, 13 (04): : A470 - A470
  • [36] The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus
    Jin, Na
    Wang, Qi
    Zhang, Xing
    Jiang, Donghai
    Cheng, Hao
    Zhu, Kejian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (09) : 1319 - 1326
  • [37] p38 Mitogen-activated protein kinase inhibitor SB203580 reverses the antianalgesia induced by dextro-morphine or morphine in the mouse spinal cord
    Wu, Hsiang-en
    Sun, Han-Sen
    Cheng, Caleb W.
    Tseng, Leon F.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 550 (1-3) : 91 - 94
  • [38] Administration of SB203580, a p38 MAPK Inhibitor, Reduced the Expression of MMP9, and Relieved Neurologic Severity in the Experimental Autoimmune Neuritis (EAN) in Rats
    Yanyan Sun
    Hongping Chen
    Shuainan Ma
    Lixin Liang
    Yi Zheng
    Xiao Guo
    Mingfei Wang
    Wei Wang
    Guozhong Li
    Di Zhong
    Neurochemical Research, 2015, 40 : 1410 - 1420
  • [39] SB203580, a p38 mitogen-activated protein kinase inhibitor, fails to improve functional outcome following a moderate spinal cord injury in rat
    Stirling, D. P.
    Liu, J.
    Plunet, W.
    Steeves, J. D.
    Tetzlaff, W.
    NEUROSCIENCE, 2008, 155 (01) : 128 - 137
  • [40] Administration of SB203580, a p38 MAPK Inhibitor, Reduced the Expression of MMP9, and Relieved Neurologic Severity in the Experimental Autoimmune Neuritis (EAN) in Rats
    Sun, Yanyan
    Chen, Hongping
    Ma, Shuainan
    Liang, Lixin
    Zheng, Yi
    Guo, Xiao
    Wang, Mingfei
    Wang, Wei
    Li, Guozhong
    Zhong, Di
    NEUROCHEMICAL RESEARCH, 2015, 40 (07) : 1410 - 1420
12345